BDRX Stock Summary and Trading Ideas (Biodexa Pharmaceuticals PLC - American Depositary Shares | NASDAQ:BDRX)

Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.

Biodexa Pharmaceuticals PLC - American Depositary Shares trades on the NASDAQ stock market under the symbol BDRX.

As of April 2, 2026, BDRX stock price climbed to $0.87 with 107,552,301 million shares trading.

BDRX has a beta of 0.45, meaning it tends to be less sensitive to market movements. BDRX has a correlation of 0.01 to the broad based SPY ETF.

BDRX has a market cap of $732,513.00. This is considered a Sub-Micro Cap stock.

In the last 3 years, BDRX traded as high as $7,500.00 and as low as $.60.

BDRX has underperformed the market in the last year with a return of -94.3%, while the SPY ETF gained +17.5%. In the last 3 month period, BDRX fell short of the market, returning -64.5%, while SPY returned -3.7%. However, in the most recent 2 weeks BDRX has outperformed the stock market by returning +27.3%, while SPY returned -0.1%.

BDRX support price is $.57 and resistance is $.66 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BDRX shares will trade within this expected range on the day.